The AI in pharmacovigilance market is expected to grow at a CAGR of 12–15% from 2023 to 2030, driven by the need to automate ...
ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the acquisition of Truliant Consulting ...
This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.
Carina Birt, Sarum Life Sciences Limited • Biologit for Local Literature™ delivers results 15 x faster than traditional searches, and is considerably more accurate and reliable • The new ...
For corporate leaders, the real path to AI success lies in comparing AI models to benchmarks that match your specific ...
Biologit boosts patient safety with automated local literature monitoring solution for non-indexed sources: Dublin, Ireland Friday, April 4, 2025, 18:00 Hrs [IST] Biologit, a spec ...
A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in ...
With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, ...
The dynamic international biotech market is continuously reviewing its target markets for entry or expansion, to optimise its ...